Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Prostate-specific antigen (PSA) values in patients with low- and high-risk prostatic adenocarcinoma (CROSBI ID 287231)

Prilog u časopisu | izvorni znanstveni rad | domaća recenzija

Mašić, Silvija ; Pezelj, Ivan ; Krušlin, Božo Prostate-specific antigen (PSA) values in patients with low- and high-risk prostatic adenocarcinoma // Acta clinica Croatica, 58 (2019), Suppl. 2; 12-16. doi: 10.20471/acc.2019.58.s2.02

Podaci o odgovornosti

Mašić, Silvija ; Pezelj, Ivan ; Krušlin, Božo

engleski

Prostate-specific antigen (PSA) values in patients with low- and high-risk prostatic adenocarcinoma

Prostatic adenocarcinoma (PC) comprises around 19% of malignancies in Croatian male population. On the basis of PSA value, Gleason score, grading group and clinical stage, PC can be classified into low- and high-risk groups which is significant for different therapeutic regimens and prognostic outcomes. In this retrospective study, we analyzed the difference in preoperative PSA value in a group of 272 patients who underwent radical prostatectomy and were diagnosed with PC adenocarcinoma in our institution in a period from January 1st, 2018 untill December 31st, 2018. Subsequently, they were divided into low- and high-risk prostatic adenocarcinoma groups. Our results demonstrated positive correlation in preoperative PSA values between the groups and therefore support the use

prostatic adenocarcinoma ; psa ; gleason grade ; low-risk ; high-risk

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

58 (Suppl. 2)

2019.

12-16

objavljeno

0353-9466

1333-9451

10.20471/acc.2019.58.s2.02

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost